Article
Interaction of mutants of tissue-type plasminogen activator with liver cells: effect of domain deletions.
The Biochemical journal - 1 Feb 1996
Kuiper J, Van't Hof A, Otter M, Biessen E A, Rijken D C, van Berkel T J
Abstract excerpt
The fibrin-specific thrombolyticum tissue-type plasminogen activator (t-PA) has proven to be a potent drug in several clinical trials, but its clinical application is complicated by the rapid clearance of t-PA from the circulation. The rapid plasma clearance of t-PA results from the uptake of t-PA in the liver. t-PA consists of several domains which may be involved in the interaction with the liver. Three...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
